FDA Grants Approval for Eltrombopag Olamine ANDA208815
The FDA has granted approval for ANDA208815, a generic version of Eltrombopag Olamine by Actavis Labs.
Therapeutic Area
Therapeutic area intelligence for Thrombocytopenia with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.